Skip to search formSkip to main contentSkip to account menu

morphine-6-glucuronide

Known as: beta-D-Glucopyranosiduronic acid, (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl, morphine 6 glucuronide, morphine-6beta-glucuronide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
BACKGROUND Morphine-6-glucuronide (M6G) is a strong µ-receptor agonist with higher affinity than morphine itself. It has been… 
Highly Cited
2003
Highly Cited
2003
Our objective was to quantify the extent and time course of the effects of morphine‐6‐glucuronide and morphine on pain threshold… 
Review
2001
Review
2001
Morphine-6-β-glucuronide (M6G) is an opioid agonist that plays a role in the clinical effects of morphine. Although M6G probably… 
Highly Cited
2000
Highly Cited
2000
BackgroundAnimal and human studies indicate the existence of important sex-related differences in opioid-mediated behavior. In… 
Highly Cited
1999
Highly Cited
1999
Morphine produces analgesia by activating mu opioid receptors encoded by the MOR–1 gene. Although morphine–6β–glucuronide (M6G… 
Highly Cited
1992
Highly Cited
1992
1. The pharmacokinetics, cardio-respiratory effects and analgesic effects of intravenous morphine-6-glucuronide were studied in… 
Highly Cited
1986
Highly Cited
1986
Patients with impaired renal function may experience severe and prolonged respiratory depression when treated with morphine. This…